Regression of hypertensive left ventricular hypertrophy and left ventricular diastolic function

Area of Science:

• Cardiology
• Hypertension Research
• Echocardiography

Background:

• Left ventricular hypertrophy (LVH) is a common complication of hypertension.
• LVH can impair left ventricular diastolic function.
• The impact of antihypertensive therapy on LVH regression and diastolic function requires further investigation.

Purpose of the Study:

• To investigate the effects of antihypertensive therapy on left ventricular hypertrophy (LVH) regression.
• To assess changes in left ventricular diastolic function during antihypertensive treatment.
• To determine the relationship between LVH regression and diastolic function.

Main Methods:

• 25 hypertensive patients received antihypertensive therapy for up to 18 months.
• Left ventricular mass index (LVMI) was measured using two-dimensional echocardiography.
• Left ventricular diastolic function was assessed via transmitral pulsed Doppler ultrasound.

Main Results:

• A significant reduction in LVMI was observed after 9 months of treatment.
• Only 13 patients showed LVMI reduction exceeding intraobserver variability.
• No significant changes in Doppler indices of left ventricular diastolic function were noted.
• Diastolic function remained unchanged even after LVH regression.

Conclusions:

• Antihypertensive therapy can lead to regression of left ventricular hypertrophy.
• Regression of LVH does not necessarily improve left ventricular diastolic function.
• There appears to be no direct relationship between left ventricular mass and abnormal diastolic function in hypertensive patients.